Search results: Sage Journals

Open accessResearch articleFirst published September, 2019

Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users

Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers

Contemporary Drug Problems

Open accessReview articleFirst published August, 2016

On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances

Vadim Shevyrin, Vladimir Melkozerov, Gregory W. Endres [...]

Cannabis & Cannabinoid Research

Free accessResearch articleFirst published March, 2017

Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?

Loretta T Ford, Jonathan D Berg

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Open accessResearch articleFirst published August, 2024

Methylenedioxymethamphetamine is a connectogen with empathogenic,entactogenic,and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”

Kurt Stocker, Matthias E Liechti

Journal of Psychopharmacology

Restricted accessResearch articleFirst published August, 2017

Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness

Matthias Forstmann, Christina Sagioglou

Journal of Psychopharmacology

Open accessReview articleFirst published January, 2024

Drug–drug interactions involving classic psychedelics: A systematic review

Andreas Halman, Geraldine Kong, Jerome Sarris [...]

Journal of Psychopharmacology

Free accessReview articleFirst published April, 2015

Legal highs: staying on top of the flood of novel psychoactive substances

David Baumeister, Luis M. Tojo, Derek K. Tracy

Therapeutic Advances in Psychopharmacology

Open accessReview articleFirst published April 14, 2010

Role of the Central Ascending Neurotransmitter Systems in the Psychostimulant Effects of Caffeine

Sergi Ferré

Journal of Alzheimer’s Disease

Open accessReview articleFirst published 2022

Synthetic opioids: a review and clinical update

Abu Shafi, Alex J. Berry, Harry Sumnall [...]

Therapeutic Advances in Psychopharmacology

Restricted accessResearch articleFirst published March, 2019

Metabolomics predicts the pharmacological profile of new psychoactive substances

Eulàlia Olesti, Ilario De Toma, Johannes G Ramaekers [...]

Journal of Psychopharmacology

Open accessResearch articleFirst published September, 2019

Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users

Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers

Contemporary Drug Problems

Open accessReview articleFirst published August, 2016

On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances

Vadim Shevyrin, Vladimir Melkozerov, Gregory W. Endres [...]

Cannabis & Cannabinoid Research

Free accessResearch articleFirst published March, 2017

Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?

Loretta T Ford, Jonathan D Berg

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Open accessResearch articleFirst published August, 2024

Methylenedioxymethamphetamine is a connectogen with empathogenic,entactogenic,and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”

Kurt Stocker, Matthias E Liechti

Journal of Psychopharmacology

Restricted accessResearch articleFirst published August, 2017

Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness

Matthias Forstmann, Christina Sagioglou

Journal of Psychopharmacology

Open accessReview articleFirst published January, 2024

Drug–drug interactions involving classic psychedelics: A systematic review

Andreas Halman, Geraldine Kong, Jerome Sarris [...]

Journal of Psychopharmacology

Free accessReview articleFirst published April, 2015

Legal highs: staying on top of the flood of novel psychoactive substances

David Baumeister, Luis M. Tojo, Derek K. Tracy

Therapeutic Advances in Psychopharmacology

Open accessReview articleFirst published April 14, 2010

Role of the Central Ascending Neurotransmitter Systems in the Psychostimulant Effects of Caffeine

Sergi Ferré

Journal of Alzheimer’s Disease

Open accessReview articleFirst published 2022

Synthetic opioids: a review and clinical update

Abu Shafi, Alex J. Berry, Harry Sumnall [...]

Therapeutic Advances in Psychopharmacology

Restricted accessResearch articleFirst published March, 2019

Metabolomics predicts the pharmacological profile of new psychoactive substances

Eulàlia Olesti, Ilario De Toma, Johannes G Ramaekers [...]

Journal of Psychopharmacology